创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: A Comprehensive Analysis of the FACS Platform's Technical Characteristics

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-01 16:14
  • Views:

(Summary description)The FACS (Fluorescence Activated Cell Sorting) platform from InnoModels Biotechnology has revolutionized the field of cellular analysis. With its outstanding features, this advanced platform provides researchers with a comprehensive and efficient solution for cellular analysis

InnoModels Biotechnology: A Comprehensive Analysis of the FACS Platform's Technical Characteristics

(Summary description)The FACS (Fluorescence Activated Cell Sorting) platform from InnoModels Biotechnology has revolutionized the field of cellular analysis. With its outstanding features, this advanced platform provides researchers with a comprehensive and efficient solution for cellular analysis

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-01 16:14
  • Views:
Information

The FACS (Fluorescence Activated Cell Sorting) platform from InnoModels Biotechnology has revolutionized the field of cellular analysis. With its outstanding features, this advanced platform provides researchers with a comprehensive and efficient solution for cellular analysis.
Features of FACS platform
1. High sensitivity and precision:
The FACS platform realizes high sensitivity and precise analysis of cells and their molecular levels with its superior fluorescence detection system. The unique optical design and advanced detection technology enable researchers to more accurately detect and analyze biomarkers on the cell surface and inside, providing a reliable tool for in-depth cellular research.
2. Multi-parameter and multi-channel analysis:
The FACS platform supports multi-parameter and multi-channel analysis for simultaneous detection of multiple markers. This feature enables researchers to obtain more comprehensive cellular information in a single experiment, providing more comprehensive data support for solving complex biological problems.
3. High throughput and rapid sorting:
The FACS platform stands out for its high-throughput cell sorting capability. It is able to process a large number of cells in a short period of time for efficient cell sorting. This provides strong support for high-throughput experiments and cell engineering studies, greatly improving research efficiency.

 


4. Automated operation and user-friendliness:
The platform is designed to focus on user experience with automated operation and intuitive user interface. Researchers can easily carry out experimental design, operation and data analysis, which makes the technology easier to operate, reduces the learning curve and improves the success rate of experiments.
5. Widely used in cell biology research:
The FACS platform is widely used in cell biology research, including cell cycle analysis, surface marker detection, and apoptosis analysis. Its versatility enables researchers to apply it flexibly in different cell research fields, providing comprehensive technical support for cell research.
Scientific Applications and Future Prospects
1. Immunology and immunotherapy research:
In immunology and immunotherapy research, the FACS platform can be used to analyze immune cell subpopulations, monitor cytokine release, etc., providing a powerful tool for studying immune responses.
2. stem cell research:
In the stem cell field, the FACS platform can be used to sort and analyze stem cell subpopulations, providing support for stem cell therapy and regenerative medicine research.
3. cancer research:
FACS platform has a wide range of applications in cancer research, and can be used to detect tumor cell subpopulations, analyze cancer cell apoptosis, etc., providing key information for cancer research.
Conclusion
The FACS platform of InnoModels Biotechnology has opened new doors of cell analysis for researchers with its excellent technical features. With the continuous upgrading of the technology and the expansion of application areas, the FACS platform is expected to play an even more important role in the fields of cell biology, medical research and drug development. InnoModels Biotechnology is committed to providing researchers with advanced technological tools to promote the continuous progress of life sciences.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司